{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T12:43:19Z","timestamp":1789735399197,"version":"4.0.1"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2018,4,14]],"date-time":"2018-04-14T00:00:00Z","timestamp":1523664000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Metab Brain Dis"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1007\/s11011-018-0236-0","type":"journal-article","created":{"date-parts":[[2018,4,14]],"date-time":"2018-04-14T06:05:09Z","timestamp":1523685909000},"page":"1223-1227","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Four Gaucher disease type II patients with three novel mutations: a single centre experience from Turkey"],"prefix":"10.1007","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0529-2404","authenticated-orcid":false,"given":"Fatma Derya","family":"Bulut","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deniz","family":"K\u00f6r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berna","family":"\u015eeker-Y\u0131lmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d6zlem","family":"Herg\u00fcner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serdar","family":"Ceylaner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferda","family":"\u00d6zk\u0131nay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebile","family":"K\u0131lavuz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neslihan","family":"\u00d6nenli-Mungan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,4,14]]},"reference":[{"issue":"9","key":"236_CR1","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1016\/0046-8177(95)90097-7","volume":"26","author":"KE Bove","year":"1995","unstructured":"Bove KE, Daugherty C, Grabowski GA (1995) Pathological findings in Gaucher disease type 2 patients following enzyme therapy. Hum Pathol 26(9):1040\u20131045","journal-title":"Hum Pathol"},{"issue":"2","key":"236_CR2","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.bcmd.2005.04.007","volume":"35","author":"A Chab\u00e1s","year":"2005","unstructured":"Chab\u00e1s A, Gort L, D\u00edaz-Font A, Montfort M, Santamar\u00eda R, Cidr\u00e1s M, Grinberg D, Vilageliu L (2005) Perinatal lethal phenotype with generalized ichthyosis in a type 2 Gaucher disease patient with the [L444P;E326K]\/P182L genotype: effect of the E326K change in neonatal and classic forms of the disease. Blood Cells Mol Dis 35(2):253\u2013258","journal-title":"Blood Cells Mol Dis"},{"issue":"18","key":"236_CR3","doi-asserted-by":"publisher","first-page":"2835","DOI":"10.1001\/archinte.160.18.2835","volume":"160","author":"J Charrow","year":"2000","unstructured":"Charrow J, Andersson HC, Kaplan P, Kolodny EH, Mistry P, Pastores G, Rosenbloom BE, Scott CR, Wappner RS, Weinreb NJ, Zimran A (2000) The Gaucher registry: demographics and disease characteristics of 1698 patients with Gaucher disease. Arch Intern Med 160(18):2835\u20132843","journal-title":"Arch Intern Med"},{"issue":"2","key":"236_CR4","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1002\/ajmg.a.20445","volume":"128A","author":"U Felderhoff-Mueser","year":"2004","unstructured":"Felderhoff-Mueser U, Uhl J, Penzel R, van Landeghem F, Vogel M, Obladen M, Kopitz J (2004) Intrauterine onset of acute neuropathic type 2 Gaucher disease: identification of a novel insertion sequence. Am J Med Genet A 128A(2):138\u2013143","journal-title":"Am J Med Genet A"},{"key":"236_CR5","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1136\/adc.63.7.854","volume":"63","author":"K Lui","year":"1988","unstructured":"Lui K, Commens C, Chong R, Jaworski R (1988) Collodion babies with Gauchers disease. Arch Dis Child 63:854\u2013856","journal-title":"Arch Dis Child"},{"key":"236_CR6","first-page":"475","volume":"3","author":"C Oberling","year":"1927","unstructured":"Oberling C, Woringer P (1927) La maladie de Gaucher chez la nourisson. Rev Fr Pediatr 3:475\u2013532","journal-title":"Rev Fr Pediatr"},{"key":"236_CR7","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1111\/cge.12828","volume":"91","author":"S Saral","year":"2017","unstructured":"Saral S, Vural A, Wollenberg A, Ruzicka T (2017) A practical approach to ichthyoses with systemic manifestations. Clin Genet 91:799\u2013812","journal-title":"Clin Genet"},{"key":"236_CR8","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1203\/00006450-199210000-00023","volume":"32","author":"E Sidransky","year":"1992","unstructured":"Sidransky E, Sherer DM, Ginns EI (1992) Gaucher disease in the neonate: a distinct Gaucher phenotype is analogous to a mouse model created by targeted disruption of the glucocerebrosidase gene. Pediatr Res 32:494\u2013498","journal-title":"Pediatr Res"},{"key":"236_CR9","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1203\/00006450-199601000-00020","volume":"39","author":"E Sidransky","year":"1996","unstructured":"Sidransky E, Fartasch M, Lee RE, Metlay LA, Abella S, Zimran A, Gao W, Elias PM, Ginns EI, Holleran WM (1996) Epidermal abnormalities may distinguish type 2 from type 1 and type 3 of Gaucher disease. Pediatr Res 39:134\u2013141","journal-title":"Pediatr Res"},{"issue":"4","key":"236_CR10","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/sj.ejhg.5200315","volume":"7","author":"DL Stone","year":"1999","unstructured":"Stone DL, van Diggelen OP, de Klerk JB et al (1999) Is the perinatal lethal form of Gaucher disease more common than classic type 2 Gaucher disease? Eur J Hum Genet 7(4):505\u2013509","journal-title":"Eur J Hum Genet"},{"issue":"2","key":"236_CR11","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1002\/(SICI)1098-1004(200002)15:2<181::AID-HUMU7>3.0.CO;2-S","volume":"15","author":"DL Stone","year":"2000","unstructured":"Stone DL, Tayebi N, Orvisky E, Stubblefield B, Madike V, Sidransky E (2000) Glucocerebrosidase gene mutations in patients with type 2 Gaucher disease. Hum Mutat 15(2):181\u2013188","journal-title":"Hum Mutat"},{"key":"236_CR12","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.ymgme.2014.11.008","volume":"114","author":"K Weiss","year":"2015","unstructured":"Weiss K, Gonzalez AN, Lopez G, Pedoeim L, Groden C, Sidransky E (2015) The clinical management of type 2 Gaucher disease. Mol Genet Metab 114:110\u2013122","journal-title":"Mol Genet Metab"}],"container-title":["Metabolic Brain Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11011-018-0236-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-018-0236-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-018-0236-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,13]],"date-time":"2019-04-13T19:14:08Z","timestamp":1555182848000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11011-018-0236-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,14]]},"references-count":12,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["236"],"URL":"https:\/\/doi.org\/10.1007\/s11011-018-0236-0","relation":{},"ISSN":["0885-7490","1573-7365"],"issn-type":[{"value":"0885-7490","type":"print"},{"value":"1573-7365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,14]]},"assertion":[{"value":"17 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"There are no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"Ethical committee approval is not required for retrospective clinical studies.Patient consent statements were obtained from all of the patients\u2019 legal guardians, also for usage of patient pictures.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Additional informed consent was obtained from all individual participants for whom identifying information is included in this article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}